TP53 and neoplasm: In line with the previously reported mechanism of actions32,33, our COMPARE correlation analyses, a large-scale exercise using hundreds of drug sensitivity datasets annotated for the mechanisms of action, showed that the anti-tumour profile of MI-773 was similar to those of Nutlin-3a and RG-7112, other antagonists targeting the p53–MDM2 interaction.